Blend Labs Discloses Material Weaknesses in Internal Controls Amidst Q1 Financial Improvements
Summary
Blend Labs, Inc. reported Q1 2026 financial results with increased revenue and reduced net loss, but disclosed two material weaknesses in internal control over financial reporting and a significant decrease in operating cash flow.
Key Events
-
Material Weaknesses in Internal Controls Identified
Management concluded that disclosure controls and internal control over financial reporting were not effective as of March 31, 2026, due to material weaknesses in revenue recognition controls and IT general controls.
-
Q1 2026 Financial Performance
The company reported a GAAP net loss of $(8.0) million, or $(0.05) per share, for Q1 2026, an improvement from $(9.7) million, or $(0.06) per share, in Q1 2025. Revenue increased 15% year-over-year to $30.8 million, and gross profit rose 23% to $23.4 million.
-
Operating Cash Flow Decline
Net cash provided by operating activities from continuing operations decreased significantly to $8.5 million in Q1 2026 from $19.8 million in Q1 2025.
-
Share Repurchase Program Update
Blend Labs repurchased $16.6 million of Class A common stock during Q1 2026 under the $50 million program authorized on March 10, 2026. An additional $2.0 million in repurchases settled after quarter-end.
Analysis
Blend Labs, Inc.'s Q1 2026 report presents a mixed financial picture, with revenue growth and a reduced net loss, but a significant decline in operating cash flow. The most critical disclosure is the identification of two material weaknesses in internal control over financial reporting, which raises concerns about the reliability of financial reporting and disclosure processes. While the company is actively addressing these weaknesses, they represent a substantial risk to investor confidence. The ongoing share repurchase program and the expiration of a dilutive warrant are positive developments, but the control deficiencies and reduced operating cash flow warrant a cautious outlook.
At the time of this filing, BLND was trading at $1.60 on NYSE in the Technology sector, with a market capitalization of approximately $416.5M. The 52-week trading range was $1.33 to $4.49. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.